• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过生物信息学和实验验证,鉴定 ISG15 和 ZFP36 为新型低氧和免疫相关基因标志物,为前列腺癌的治疗提供新视角。

Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.

机构信息

Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

出版信息

J Transl Med. 2022 May 10;20(1):202. doi: 10.1186/s12967-022-03398-4.

DOI:10.1186/s12967-022-03398-4
PMID:35538543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9092714/
Abstract

BACKGROUND

Prostatic cancer (PCa) is one of the most common malignant tumors in men worldwide. Emerging evidence indicates significance of hypoxia and immunity in PCa invasion and metastasis. This study aimed to develop a hypoxia- and immune-related gene risk signature and explore the molecular mechanisms to formulate a better prognostic tool for PCa patients.

METHODS

The hypoxia and immune scores of all PCa patients in The Cancer Genome Atlas (TCGA) dataset were calculated via the maximally selected rank statistics method and the ESTIMATE algorithm. From common genes identified overlapping hypoxia- and immune-related differentially expressed genes (DE-HRGs and DE-IRGs), a hypoxia- and immune-related gene risk signature was developed utilizing univariate and multivariate Cox regression analyses, and validated in the Memorial Sloan Kettering Cancer Centre (MSKCC) database. The immune cell infiltration level of PCa samples were evaluated with ssGSEA algorithm. Differential expression of prognostic genes was evidenced by immunohistochemistry and western blot (WB) in paired PCa samples. Expression levels of these genes and their variations under regular and hypoxic conditions were examined in cell lines. The functional effects of the prognostic gene on PCa cells were examined by wound healing and transwell assays.

RESULTS

A hypoxia- and immune-related gene risk signature constructed by ISG15 and ZFP36 displays significant predictive potency, with higher risk score representing worse survival. A nomogram based on independent prognostic factors including the risk score and Gleason score exhibited excellent clinical value in the survival prediction of PCa. Infiltration levels of eosinophils, neutrophils, Tcm, Tem, TFH, Th1 cells, and Th17 cells were significantly lower in the high-risk group. Conversely, aDC, pDC, T helper cells, and Tregs were significantly higher. Additionally, the two prognostic genes were closely correlated with the tumor-infiltrating immune cell subset in PCa progression. RT-qPCR and WB presented higher and lower expression of ISG15 and ZFP36 in PCa cells, respectively. They were correspondingly increased and decreased in PCa cells under hypoxic conditions. Wound healing and transwell assays showed that over-expression of ISG15 promoted the migration and invasion of PCa cells.

CONCLUSION

Our study identified a novel hypoxia- and immune-related gene signature, contributing a new perspective to the treatment of PCa.

摘要

背景

前列腺癌(PCa)是全球男性中最常见的恶性肿瘤之一。新出现的证据表明,缺氧和免疫在 PCa 的侵袭和转移中具有重要意义。本研究旨在开发一个与缺氧和免疫相关的基因风险特征,并探讨其分子机制,为 PCa 患者制定更好的预后工具。

方法

通过最大选择秩统计方法和 ESTIMATE 算法计算 TCGA 数据集所有 PCa 患者的缺氧和免疫评分。从共同的基因中鉴定重叠的与缺氧和免疫相关的差异表达基因(DE-HRGs 和 DE-IRGs),利用单变量和多变量 Cox 回归分析开发一个与缺氧和免疫相关的基因风险特征,并在 Memorial Sloan Kettering Cancer Centre(MSKCC)数据库中进行验证。利用 ssGSEA 算法评估 PCa 样本的免疫细胞浸润水平。通过免疫组织化学和 Western blot(WB)在配对的 PCa 样本中证实预后基因的差异表达。在细胞系中检查这些基因的表达水平及其在常氧和缺氧条件下的变化。通过划痕愈合和 Transwell 测定检查预后基因对 PCa 细胞的功能影响。

结果

由 ISG15 和 ZFP36 构建的与缺氧和免疫相关的基因风险特征具有显著的预测能力,风险评分越高代表预后越差。基于独立预后因素(包括风险评分和 Gleason 评分)的列线图在 PCa 患者的生存预测中具有优异的临床价值。在高危组中,嗜酸性粒细胞、中性粒细胞、Tcm、Tem、TFH、Th1 细胞和 Th17 细胞的浸润水平显著降低。相反,aDC、pDC、T 辅助细胞和 Tregs 则显著升高。此外,这两个预后基因与 PCa 进展中的肿瘤浸润免疫细胞亚群密切相关。RT-qPCR 和 WB 显示,PCa 细胞中 ISG15 和 ZFP36 的表达水平更高和更低。在缺氧条件下,PCa 细胞中的表达水平相应增加和减少。划痕愈合和 Transwell 测定表明,ISG15 的过表达促进了 PCa 细胞的迁移和侵袭。

结论

本研究鉴定了一个新的与缺氧和免疫相关的基因特征,为 PCa 的治疗提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/212e059aa55a/12967_2022_3398_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/78c926dacefb/12967_2022_3398_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/07316b262224/12967_2022_3398_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/f613f6ba6a5e/12967_2022_3398_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/a431bf8c027d/12967_2022_3398_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/47abdeacfed7/12967_2022_3398_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/d5841831486c/12967_2022_3398_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/4443fe0d800a/12967_2022_3398_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/212e059aa55a/12967_2022_3398_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/78c926dacefb/12967_2022_3398_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/07316b262224/12967_2022_3398_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/f613f6ba6a5e/12967_2022_3398_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/a431bf8c027d/12967_2022_3398_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/47abdeacfed7/12967_2022_3398_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/d5841831486c/12967_2022_3398_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/4443fe0d800a/12967_2022_3398_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d22/9092714/212e059aa55a/12967_2022_3398_Fig8_HTML.jpg

相似文献

1
Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.通过生物信息学和实验验证,鉴定 ISG15 和 ZFP36 为新型低氧和免疫相关基因标志物,为前列腺癌的治疗提供新视角。
J Transl Med. 2022 May 10;20(1):202. doi: 10.1186/s12967-022-03398-4.
2
Comprehensive scRNA-seq analysis to identify new markers of M2 macrophages for predicting the prognosis of prostate cancer.综合单细胞 RNA 测序分析鉴定 M2 巨噬细胞的新标志物用于预测前列腺癌的预后。
Ann Med. 2024 Dec;56(1):2398195. doi: 10.1080/07853890.2024.2398195. Epub 2024 Sep 2.
3
A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.一个联合缺氧和免疫基因特征,用于预测三阴性乳腺癌的生存和风险分层。
Aging (Albany NY). 2021 Aug 2;13(15):19486-19509. doi: 10.18632/aging.203360.
4
A bioinformatics analysis and an experimental validation of the hypoxia-related prognostic model.缺氧相关预后模型的生物信息学分析与实验验证。
J Gastrointest Oncol. 2023 Jun 30;14(3):1504-1524. doi: 10.21037/jgo-23-301. Epub 2023 Jun 19.
5
ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress.ZFP36 通过靶向 CDK6 和氧化应激抑制人前列腺癌的肿瘤进展。
Oxid Med Cell Longev. 2022 Sep 6;2022:3611540. doi: 10.1155/2022/3611540. eCollection 2022.
6
Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.结肠癌中缺氧相关亚型的鉴定、预后模型的建立及肿瘤微环境浸润特征
Front Genet. 2022 Jun 17;13:919389. doi: 10.3389/fgene.2022.919389. eCollection 2022.
7
Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer.鉴定和验证前列腺癌骨转移免疫相关基因的新的总生存预测模型。
Aging (Albany NY). 2023 Jul 25;15(14):7161-7186. doi: 10.18632/aging.204900.
8
Classification of pyroptosis patterns and construction of a novel prognostic model for prostate cancer based on bulk and single-cell RNA sequencing.基于 bulk 和单细胞 RNA 测序的前列腺癌焦亡模式分类和新型预后模型的构建。
Front Endocrinol (Lausanne). 2022 Aug 29;13:1003594. doi: 10.3389/fendo.2022.1003594. eCollection 2022.
9
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.TMEFF2 调控的细胞周期相关基因特征可预测前列腺癌的复发风险。
BMC Cancer. 2019 May 6;19(1):423. doi: 10.1186/s12885-019-5592-6.
10
Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram.鉴定与根治性切除术相关的前列腺癌免疫浸润的复发标志物,并构建预后列线图。
BMC Cancer. 2019 Dec 3;19(1):1179. doi: 10.1186/s12885-019-6391-9.

引用本文的文献

1
Identification and validation of prognostic biomarkers in ccRCC: immune-stromal score and survival prediction.肾透明细胞癌中预后生物标志物的鉴定与验证:免疫-基质评分与生存预测
BMC Cancer. 2025 Jan 27;25(1):148. doi: 10.1186/s12885-025-13534-0.
2
Comparative Transcriptomes of Canine and Human Prostate Cancers Identify Mediators of Castration Resistance.犬和人前列腺癌的比较转录组鉴定去势抵抗的介质。
Vet Comp Oncol. 2024 Dec;22(4):629-640. doi: 10.1111/vco.13017. Epub 2024 Oct 7.
3
Decoding the immune microenvironment: unveiling CD8 + T cell-related biomarkers and developing a prognostic signature for personalized glioma treatment.

本文引用的文献

1
F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition.F-FMISO PET 成像可识别缺氧和免疫抑制性肿瘤微环境,并指导针对 PD-1 和 CTLA-4 抑制耐药肿瘤的靶向依氟鸟氨酸治疗。
Clin Cancer Res. 2022 Jan 15;28(2):327-337. doi: 10.1158/1078-0432.CCR-21-2394. Epub 2021 Oct 6.
2
Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy.肿瘤缺氧介导的免疫抑制:改善癌症免疫治疗的机制和治疗方法。
Cells. 2021 Apr 24;10(5):1006. doi: 10.3390/cells10051006.
3
解码免疫微环境:揭示CD8 + T细胞相关生物标志物并开发用于个性化胶质瘤治疗的预后特征。
Cancer Cell Int. 2024 Oct 1;24(1):331. doi: 10.1186/s12935-024-03517-9.
4
Identification of RTP4 facilitating ovarian cancer by bioinformatics analysis and experimental validation.通过生物信息学分析和实验验证鉴定促进卵巢癌的RTP4
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2665-2675. doi: 10.1007/s00210-024-03421-z. Epub 2024 Sep 9.
5
Development and validation of a hypoxia- and mitochondrial dysfunction- related prognostic model based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer.基于单细胞和 bulk RNA 测序分析的胃癌缺氧和线粒体功能障碍相关预后模型的建立和验证。
Front Immunol. 2024 Aug 6;15:1419133. doi: 10.3389/fimmu.2024.1419133. eCollection 2024.
6
Protumorigenic Interferon-Stimulated Genes in Cancer: A Comprehensive Review.癌症中促肿瘤发生的干扰素刺激基因:综述
Cureus. 2024 Jun 26;16(6):e63216. doi: 10.7759/cureus.63216. eCollection 2024 Jun.
7
The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma.铜死亡相关免疫基因signature 预测前列腺腺癌的肿瘤微环境和预后。
Front Immunol. 2023 Aug 2;14:1181370. doi: 10.3389/fimmu.2023.1181370. eCollection 2023.
8
Advancements in MRI-Based Radiomics and Artificial Intelligence for Prostate Cancer: A Comprehensive Review and Future Prospects.基于磁共振成像的放射组学和人工智能在前列腺癌中的进展:全面综述与未来展望
Cancers (Basel). 2023 Jul 28;15(15):3839. doi: 10.3390/cancers15153839.
9
OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment.OX40L 武装溶瘤病毒增强 T 细胞反应并重塑胰腺癌治疗的肿瘤微环境。
Theranostics. 2023 Jul 9;13(12):4016-4029. doi: 10.7150/thno.83495. eCollection 2023.
10
ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma.ISG15 靶向糖基化 PD-L1 并促进其降解,以增强肺腺癌中的抗肿瘤免疫效应。
J Transl Med. 2023 May 22;21(1):341. doi: 10.1186/s12967-023-04135-1.
Hypothesis: The triad androgen receptor, zinc finger proteins and telomeres modulates the global gene expression pattern during prostate cancer progression.
假设:雄激素受体、锌指蛋白和端粒三联体在前列腺癌进展过程中调节整体基因表达模式。
Med Hypotheses. 2021 May;150:110566. doi: 10.1016/j.mehy.2021.110566. Epub 2021 Mar 23.
4
Tumor Cell-Secreted ISG15 Promotes Tumor Cell Migration and Immune Suppression by Inducing the Macrophage M2-Like Phenotype.肿瘤细胞分泌的 ISG15 通过诱导巨噬细胞 M2 样表型促进肿瘤细胞迁移和免疫抑制。
Front Immunol. 2020 Dec 23;11:594775. doi: 10.3389/fimmu.2020.594775. eCollection 2020.
5
Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy.针对肿瘤微环境中的缺氧:提高癌症免疫疗法的潜在策略。
J Exp Clin Cancer Res. 2021 Jan 9;40(1):24. doi: 10.1186/s13046-020-01820-7.
6
Oxygen therapeutic agents to target hypoxia in cancer treatment.用于癌症治疗中靶向缺氧的氧疗药物。
Curr Opin Pharmacol. 2020 Aug;53:146-151. doi: 10.1016/j.coph.2020.09.009. Epub 2020 Oct 18.
7
Immune signature driven by ADT-induced immune microenvironment remodeling in prostate cancer is correlated with recurrence-free survival and immune infiltration.ADT 诱导的免疫微环境重塑驱动的前列腺癌免疫特征与无复发生存和免疫浸润相关。
Cell Death Dis. 2020 Sep 19;11(9):779. doi: 10.1038/s41419-020-02973-1.
8
Loss of EGR3 is an independent risk factor for metastatic progression in prostate cancer.EGR3 缺失是前列腺癌转移进展的独立危险因素。
Oncogene. 2020 Sep;39(36):5839-5854. doi: 10.1038/s41388-020-01418-5. Epub 2020 Aug 14.
9
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.泛癌症分析免疫细胞浸润鉴定出肺腺癌预后免疫细胞特征评分(ICCS)。
Front Immunol. 2020 Jun 30;11:1218. doi: 10.3389/fimmu.2020.01218. eCollection 2020.
10
Hypoxia Promotes Prostate Cancer Aggressiveness by Upregulating EMT-Activator Zeb1 and SK3 Channel Expression.缺氧通过上调 EMT 激活因子 Zeb1 和 SK3 通道表达促进前列腺癌侵袭转移。
Int J Mol Sci. 2020 Jul 6;21(13):4786. doi: 10.3390/ijms21134786.